MetaCap

Bon Natural Life Limited Class A (BON)

NASDAQ: BONHealth Care Medicinal Chemicals and Botanical Products USD

1.04-0.0052 (-0.50%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

BON stock chart

Technical analysis

Key statistics

All statistics
EPS (TTM)
-$2.79
52-week range
0.95 – 1.94
Day range
1.03 – 1.05
Volume / Avg
118.38K / 10.82K
Beta
—

52-week range

$0.95$1.94

BON stock today

On Nov 20, BON ended the session at $1.04, shedding $0.0052 (0.50%), versus the S&P 500's 3.70% decline. Volume was 10.9x the average at 118.38K shares, a sign of unusually heavy trading. Shares are 46.1% below their 52-week high of $1.94 and 10.0% above the 52-week low of $0.95, near the bottom of the past year's range.

Bon Natural Life has posted a net loss over the last twelve months (EPS of -$2.79), so its P/E ratio is not meaningful.

Summary generated from market data by MetaCap's automated system. Methodology

About Bon Natural Life

Company profile

Bon Natural Life Limited, together with its subsidiaries, engages in the research, development, manufacture, and sale of functional active ingredients extracted from natural herb plants in the People's Republic of China, Europe, North America, and the Middle East. The company offers personal care ingredients, such as plant extracted fragrance compounds to perfume and fragrance manufacturers; and natural health supplements comprising powder drinks and bioactive food ingredient products used as food additives and nutritional supplements. It sells its products through direct distributors.

Industry
Medicinal Chemicals and Botanical Products
CEO
Mr. Yongwei Hu
Headquarters
Xi'an
Employees
96
IPO year
2021
Website
bnlus.com

Financial highlights

Full financials

In fiscal 2025, Bon Natural Life generated $18.7 million in revenue, down 21.7% from fiscal 2024, its first annual decline since 2024. Bon Natural Life reported a net loss of $2.0 million, compared with net income of $398,172 a year earlier. Gross margin was 20.8% (down from 29.8%) and operating margin -8.7%.

Bon Natural Life annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021
Revenue$18.67M$23.84M$29.52M$29.91M$25.49M
Growth-21.70%-19.23%-1.29%+17.31%+39.93%
Net income$-1.99M$398.17K$4.60M$6.24M$4.59M
EPS (diluted)$-0.72$4.14$124.92$7.43$0.68

BON news

All BON news

Bon Natural Life peers

Health Care sector
BON peer companies
CompanyPrice% ChgMarket capCompare
AKANAkanda Corp.4.23+23.32%$11.16Mvs BON
NAIINatural Alternatives International Inc.0.876-2.67%$5.48Mvs BON
MTEXMannatech Incorporated2.56+5.13%$4.94Mvs BON
XXII22nd Century Group Inc.0.3365-15.43%$1.08Mvs BON
IMCCIM Cannabis Corp.0.4999+7.23%$307.30Kvs BON
BTMDBiote Corp. Class A0.8147-3.56%$26.28Mvs BON
FTLFFitLife Brands Inc.6.20-7.46%$58.22Mvs BON
ISPRIspire Technology Inc.1.23-3.15%$71.05Mvs BON

Indexes, lists and sector

Bon Natural Life stock FAQ

What is Bon Natural Life's stock price today?

BON last traded at $1.04 as of Nov 20, 4:00 PM EST, down 0.50% on the day. Prices are delayed at least 15 minutes.

Who is Bon Natural Life's CEO?

Mr. Yongwei Hu is the chief executive officer of Bon Natural Life Limited Class A, which has about 96 employees.

What is the BON 52-week high?

The 52-week high for BON is $1.94 and the 52-week low is $0.95. The stock is currently 46.1% below its high.

Compare BON